Loading institutional data...
Loading institutional data...
Held by 752 of 2,417 reporting institutions (99th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 55% of free cash flow, leaving room to grow it and fund buybacks. Last year: $2.81B dividends + $4.60B buybacks = $7.41B returned on $5.09B FCF.
7 consecutive years of dividend increases · 8%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 11%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $5.06B covers the $1.80B due within a year 2.8× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~1.0% on $25.19B of debt.
Cash of $5.06B fully covers short-term debt of $4.51B.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it. This year they exceeded net income, so the ribbons are capped at earnings and understate what was actually returned.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.99B 100.0% | $33.01B 100.0% | $32.85B 100.0% | $33.36B 100.0% | $30.79B 100.0% | $27.24B 100.0% | $28.23B 100.0% | $14.84B 100.0% | $11.36B 100.0% | $10.53B 100.0% |
| Cost of Products | — | — | — | — | — | — | — | $9.08B 61.2% | $6.46B 56.9% | $5.86B 55.6% |
| Research & Development | $147.0M 0.4% | $150.0M 0.5% | $146.0M 0.4% | $143.0M 0.4% | $143.0M 0.5% | $152.0M 0.6% | $184.0M 0.7% | $113.0M 0.8% | $93.0M 0.8% | $92.0M 0.9% |
| Selling, General & Admin | $3.43B 10.1% | $3.34B 10.1% | $3.29B 10.0% | $3.11B 9.3% | $3.19B 10.4% | $3.19B 11.7% | $3.46B 12.2% | $1.63B 11.0% | $1.21B 10.6% | $1.15B 10.9% |
| Operating Income | $8.92B 26.3% | $8.63B 26.2% | $8.02B 24.4% | $5.37B 16.1% | $4.98B 16.2% | $3.32B 12.2% | $2.93B 10.4% | $5.25B 35.4% | $2.44B 21.5% | $2.25B 21.3% |
| Interest Expense | $255.0M 0.8% | $256.0M 0.8% | $200.0M 0.6% | $63.0M 0.2% | $227.0M 0.7% | $277.0M 1.0% | $284.0M 1.0% | $297.0M 2.0% | $230.0M 2.0% | $208.0M 2.0% |
| Interest & Investment Income | $209.0M 0.6% | $228.0M 0.7% | $197.0M 0.6% | $117.0M 0.4% | $40.0M 0.1% | $55.0M 0.2% | $112.0M 0.4% | $80.0M 0.5% | $41.0M 0.4% | — |
| Pretax Income | $8.90B 26.2% | $8.57B 26.0% | $7.99B 24.3% | $5.54B 16.6% | $5.10B 16.6% | $3.38B 12.4% | $2.93B 10.4% | $5.05B 34.0% | $2.29B 20.1% | $2.05B 19.4% |
| Income Tax Expense | $1.99B 5.9% | $2.00B 6.1% | $1.81B 5.5% | $1.43B 4.3% | $1.26B 4.1% | $847.0M 3.1% | $769.0M 2.7% | $817.0M 5.5% | $1.03B 9.0% | $551.0M 5.2% |
| Net Income | $6.90B 20.3% | $6.57B 19.9% | $6.20B 18.9% | $4.15B 12.4% | $3.83B 12.4% | $2.50B 9.2% | $2.29B 8.1% | $4.38B 29.5% | $1.25B 11.0% | $1.50B 14.2% |
| Per Share | ||||||||||
| EPS (Basic) | $14.69 | $13.71 | $12.70 | $8.30 | $7.40 | $4.75 | $4.22 | $13.26 | $4.36 | $5.25 |
| EPS (Diluted) | $14.61 | $13.62 | $12.59 | $8.23 | $7.33 | $4.71 | $4.19 | $13.11 | $4.32 | $5.21 |
| Weighted Avg Shares (Basic) | 469.5M | 478.8M | 488.2M | 499.7M | 516.9M | 526.7M | 541.1M | 330.4M | 286.3M | 285.7M |
| Weighted Avg Shares (Diluted) | 472.2M | 482.1M | 492.3M | 504.0M | 521.9M | 531.2M | 545.2M | 334.1M | 289.1M | 287.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $514.24 today, the market must believe free cash flow compounds 12.7%/yr for a decade (off $5.18B on the 3-yr avg basis).
On the basis ($5.02B) the requirement is 13.1%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 12.7% is more optimistic than its 5-yr track record.
Default is 7.2% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.46B shares (market data) · net debt $20.14B
mean 8.0% · volatility σ 32% · implied rate exceeded in 1/5 yrs
Central path = implied 12.7%/yr growth; shaded band = ±1σ (32%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 37 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | $1.26T | 61.8× | — | 19.4× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 1,730 |
| JNJ | $657.7B | 24.8× | 20.9× | 7.0× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | 0.9× | 1,839 |
| ABBV | $521.1B | 125.0× | 36.8× | 8.5× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 3.9× | 1,635 |
| PG | $374.5B | 24.4× | 17.8× | 4.3× | 3.3% | 50.2% | 18.4% | 29.5% | 18.1% | 1.5× | 1,518 |
| MRK | $368.9B | 20.5× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 1,469 |
| AMGN | $251.9B | 32.8× | 20.9× | 6.9× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.2× | 1,228 |
| LIN | $236.1B | 35.2× | 21.1× | 7.0× | 3.0% | — | 20.3% | 18.0% | 10.9% | 1.6× | 752 |
| GILD | $211.8B | 25.2× | 22.8× | 7.2× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 787 |
| ABT | $183.8B | 28.6× | 19.8× | 4.2× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 0.5× | 1,081 |
| PFE | $174.0B | 22.4× | — | 2.8× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 1,034 |
| VRTX | $141.7B | 36.5× | 31.2× | 11.8× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | -1.2× | 568 |
| BMY | $127.7B | 18.1× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 904 |
| REGN | $95.5B | 22.4× | 22.9× | 6.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | -0.3× | 408 |
| MRNA | $88.5B | — | — | 45.5× | -39.9% | 55.3% | -145% | -32.6% | -30.5% | — | 279 |
| ECL | $84.9B | 41.6× | 27.1× | 5.3× | 2.2% | 44.5% | 12.9% | 21.2% | 11.5% | 2.2× | 541 |
| CL | $76.0B | 36.2× | 21.0× | 3.7× | 1.4% | 60.1% | 10.5% | — | 26.5% | 1.7× | 646 |
| APD | $70.5B | — | 99.9× | 5.8× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | -2.6× | 583 |
| TEVA | $49.1B | 34.8× | 18.4× | 2.8× | 4.3% | 51.8% | 8.2% | 17.8% | 14.5% | -0.7× | 7 |
| IDXX | $43.4B | 42.1× | 29.0× | 10.1× | 10.4% | 61.8% | 24.6% | 66.0% | 51.5% | 0.2× | 362 |
| ONC | $42.1B | — | 65.5× | 7.9× | 40.2% | 87.5% | 5.4% | 6.6% | 5.4% | -6.1× | 61 |
| EL | $39.6B | 218.5× | 25.4× | 2.6× | 5.0% | 75.5% | 1.2% | 4.8% | 4.2% | 0.3× | 224 |
| BIIB | $37.5B | 28.9× | 16.6× | 3.8× | 2.2% | 75.7% | 13.1% | 7.1% | 5.3% | 2.4× | 288 |
| KVUE | $37.1B | 25.4× | 12.6× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.1× | 257 |
| ZTS | $32.9B | 13.2× | 10.4× | 3.5× | 2.3% | 71.8% | 28.2% | 78.3% | 21.5% | 1.7× | 388 |
| RPRX | $29.9B | 37.7× | 24.5× | 12.6× | 5.1% | — | 32.4% | 7.9% | 4.1% | 5.3× | 161 |
Peers = companies sharing LIN's sector (Industrial Inorganic Chemicals) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 10-yr range · 88th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 10-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 18% against ROIC 11% — 7% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| R&D | 0.8 | 0.7 | 0.6 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 |
| SG&A | 11.0 | 12.2 | 11.7 | 10.4 | 9.3 | 10.0 | 10.1 | 10.1 |
| Operating Income | 35.4 | 10.4 | 12.2 | 16.2 | 16.1 | 24.4 | 26.2 | 26.3 |
| Income Tax | 5.5 | 2.7 | 3.1 | 4.1 | 4.3 | 5.5 | 6.1 | 5.9 |
| Net Income | 29.5 | 8.1 | 9.2 | 12.4 | 12.4 | 18.9 | 19.9 | 20.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on LIN: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 4.38pts above its cost of capital, without much margin of safety.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 3.7% | 7.2% (today's — no rate published for this year) | -3.4pts |
| FY2020 | 4.2% | 7.2% (today's — no rate published for this year) | -2.9pts |
| FY2021 | 7.0% | 6.5% | 0.5pts |
| FY2022 | 7.9% | 7.9% | -0.0pts |
| FY2023 | 11.3% | 7.8% | 3.6pts |
| FY2024 | 12.2% | 8.0% | 4.2pts |
| FY2025 | 11.4% | 6.9% | 4.6pts |
| Now | 10.9% | 7.2% | 3.7pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 21.3% | 14.2% |
| FY2017 | not reported | 21.5% | 11.0% |
| FY2018 | not reported | 35.4% | 29.5% |
| FY2019 | not reported | 10.4% | 8.1% |
| FY2020 | not reported | 12.2% | 9.2% |
| FY2021 | not reported | 16.2% | 12.4% |
| FY2022 | not reported | 16.1% | 12.4% |
| FY2023 | not reported | 24.4% | 18.9% |
| FY2024 | not reported | 26.2% | 19.9% |
| FY2025 | not reported | 26.3% | 20.3% |
Leverage and buybacks account for 7 points of the 18% return on equity in FY2025. The business earns 11% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$27.9B of goodwill — 47% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
ROIC ex-goodwill is 21.77% against 11.56% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.10x of reported profit into free cash flow over 5 years, with accruals negative.
Conversion has deteriorated: 0.79x over three years against 1.10x over 5.
Covers interest 10.9x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 15.52x |
| 5% | 14.74x |
| 10% | 13.97x |
| 15% | 13.19x |
| 20% | 12.41x |
| 25% | 11.64x |
| 30% | 10.86x |
| 35% | 10.09x |
| 40% | 9.31x |
| 45% | 8.54x |
| 50% | 7.76x |
| 55% | 6.98x |
| 60% | 6.21x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $514.24, free cash flow must compound 12.75%/yr for 10 years. It has done 4.78%/yr over 5 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | 64.8% | 12.7% |
| FY2022 | −14.3% | 12.7% |
| FY2023 | −3.0% | 12.7% |
| FY2024 | −10.7% | 12.7% |
| FY2025 | 3.3% | 12.7% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 1 of the last 5 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $6.90B | $6.90B |
| Share-based comp | $164M | $7.06B |
| Other non-cash & working capital | $3.29B | $10.35B |
| Operating cash flow | $10.35B | $10.35B |
| Capex | −$5.26B | $5.09B |
| Free cash flow | $5.09B | $5.09B |
| FCF after SBC | $4.92B | $4.92B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -3.5% | -3.6% | -0.1 points |
| FY2021 | 13.0% | 8.0% | -5.1 points |
| FY2022 | 8.3% | 1.3% | -7.0 points |
| FY2023 | -1.5% | 3.5% | 5.0 points |
| FY2024 | 0.5% | -2.0% | -2.5 points |
| FY2025 | 3.0% | 7.4% | 4.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 55.9 days | not reported | not reported | not reported |
| FY2020 | 55.8 days | not reported | not reported | not reported |
| FY2021 | 53.3 days | not reported | not reported | not reported |
| FY2022 | 49.9 days | not reported | not reported | not reported |
| FY2023 | 52.4 days | not reported | not reported | not reported |
| FY2024 | 51.1 days | not reported | not reported | not reported |
| FY2025 | 53.3 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | not reported |
| FY2020 | -5.6 percent |
| FY2021 | -7.2 percent |
| FY2022 | -5.9 percent |
| FY2023 | -3.8 percent |
| FY2024 | -3.6 percent |
| FY2025 | -4.0 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Reynolds Paula Rosput Director | Grant | 18 | $0.00 | — |
| 2026-10-01 | Grant Hugh Director | Grant | 72 | $0.00 | — |
| 2026-08-18 | Reynolds Paula Rosput Director | Plan purchase | 100 | $479.12 | $48k |
| 2026-07-01 | Grant Hugh Director | Grant | 64 | $0.00 | — |
| 2026-07-01 | Reynolds Paula Rosput |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Grant |
| 16 |
| $0.00 |
| — |
| 2026-06-08 | 3 co-filers SVP, Linde Engineering | Option exercise | 4,035 | $0.00 | $0 |
| 2026-06-08 | 3 co-filers SVP, Linde Engineering | Tax withholding | 2,062 | $507.90 | $1.0m |
| 2026-06-08 | 3 co-filers SVP, Linde Engineering | Option exercise | 4,035 | $0.00 | — |
| 2026-05-15 | 2 co-filers Group filing | Open-market sale | 4,335 | $506.39 | $2.2m |
| 2026-05-14 | 2 co-filers Group filing | Open-market sale | 880 | $508.76 | $448k |
| 2026-04-01 | Reynolds Paula Rosput Director | Grant | 17 | $0.00 | — |
| 2026-04-01 | Grant Hugh Director | Grant | 69 | $0.00 | — |
| 2026-03-10 | Bichara Guillermo Exec VP & Chief Legal Officer | 10b5-1 plan sale | 4,357 | $480.79 | $2.1m |
| 2026-03-10 | 5 co-filers EVP, Chief Operating Officer | Exercise & sell | 4,114 | $477.78 | $2.0m |
| 2026-03-10 | 5 co-filers EVP, Chief Operating Officer | Option exercise | 7,045 | $173.13 | $1.2m |
| 2026-03-10 | 5 co-filers EVP, Chief Operating Officer | Tax withholding | 4,639 | $476.54 | $2.2m |
| 2026-03-10 | 5 co-filers EVP, Chief Operating Officer | Exercise & sell | 2,406 | $476.41 | $1.1m |
| 2026-03-10 | 5 co-filers EVP, Chief Operating Officer | Option exercise | 7,045 | $0.00 | — |
| 2026-03-09 | 2 co-filers Group filing | Grant | 473 | $0.00 | — |
| 2026-03-09 | 2 co-filers Group filing | Grant | 473 | $0.00 | — |
| 2026-03-09 | 13 co-filers SVP, Chief HR Officer | Option exercise | 727 | $0.00 | $0 |
| 2026-03-09 | 4 co-filers Group filing | Option exercise | 470 | $0.00 | $0 |
| 2026-03-09 | 4 co-filers Group filing | Option exercise | 470 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers Exec VP & Chief Legal Officer | Option exercise | 4,762 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers Chief Financial Officer | Option exercise | 8,136 | $0.00 | $0 |
| 2026-03-09 | 8 co-filers Senior Vice President - APAC | Option exercise31d late | 548 | $0.00 | $0 |
| 2026-03-09 | 4 co-filers Group filing | Option exercise | 470 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers Chairman & CEO | Option exercise | 19,892 | $0.00 | $0 |
| 2026-03-09 | 4 co-filers Group filing | Option exercise | 470 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers SVP, Americas | Option exercise | 2,712 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers EVP, Chief Operating Officer | Option exercise | 4,526 | $0.00 | $0 |
| 2026-03-09 | 4 co-filers Group filing | Option exercise | 470 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers Senior Vice President, EMEA | Option exercise | 642 | $0.00 | $0 |
| 2026-03-09 | 2 co-filers SVP, Linde Engineering | Grant | 749 | $0.00 | — |
| 2026-03-09 | 13 co-filers Principal Accounting Officer | Option exercise | 907 | $0.00 | $0 |
| 2026-03-09 | Wood Robert L Director | Grant | 473 | $0.00 | — |
| 2026-03-09 | 13 co-filers Exec VP & Chief Legal Officer | Tax withholding | 2,207 | $484.74 | $1.1m |
| 2026-03-09 | 13 co-filers Chief Financial Officer | Tax withholding | 3,771 | $484.74 | $1.8m |
| 2026-03-09 | 8 co-filers Senior Vice President - APAC | Option exercise31d late | 195 | $0.00 | $0 |
| 2026-03-09 | 13 co-filers SVP, Americas | Tax withholding | 1,186 | $484.74 | $575k |